These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12954048)

  • 21. Synthesis and structure-activity relationships of conformationally constrained histamine H(3) receptor agonists.
    Kitbunnadaj R; Zuiderveld OP; De Esch IJ; Vollinga RC; Bakker R; Lutz M; Spek AL; Cavoy E; Deltent MF; Menge WM; Timmerman H; Leurs R
    J Med Chem; 2003 Dec; 46(25):5445-57. PubMed ID: 14640553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of human, mouse, rat, and guinea pig histamine H4 receptors reveals substantial pharmacological species variation.
    Liu C; Wilson SJ; Kuei C; Lovenberg TW
    J Pharmacol Exp Ther; 2001 Oct; 299(1):121-30. PubMed ID: 11561071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.
    Faghih R; Dwight W; Gentles R; Phelan K; Esbenshade TA; Ireland L; Miller TR; Kang CH; Fox GB; Gopalakrishnan SM; Hancock AA; Bennani YL
    Bioorg Med Chem Lett; 2002 Aug; 12(15):2031-4. PubMed ID: 12113835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of S-(2-guanidylethyl)-isothiourea (VUF 8430) as a potent nonimidazole histamine H4 receptor agonist.
    Lim HD; Smits RA; Bakker RA; van Dam CM; de Esch IJ; Leurs R
    J Med Chem; 2006 Nov; 49(23):6650-1. PubMed ID: 17154494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Major advances in the development of histamine H4 receptor ligands.
    Smits RA; Leurs R; de Esch IJ
    Drug Discov Today; 2009 Aug; 14(15-16):745-53. PubMed ID: 19477292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a homogeneous binding assay for histamine receptors.
    Crane K; Shih DT
    Anal Biochem; 2004 Dec; 335(1):42-9. PubMed ID: 15519569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel series of histamine H4 receptor antagonists based on the pyrido[3,2-d]pyrimidine scaffold: comparison of hERG binding and target residence time with PF-3893787.
    Andaloussi M; Lim HD; van der Meer T; Sijm M; Poulie CB; de Esch IJ; Leurs R; Smits RA
    Bioorg Med Chem Lett; 2013 May; 23(9):2663-70. PubMed ID: 23558237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist.
    Esbenshade TA; Fox GB; Krueger KM; Baranowski JL; Miller TR; Kang CH; Denny LI; Witte DG; Yao BB; Pan JB; Faghih R; Bennani YL; Williams M; Hancock AA
    Biochem Pharmacol; 2004 Sep; 68(5):933-45. PubMed ID: 15294456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.
    Hammer SG; Gobleder S; Naporra F; Wittmann HJ; Elz S; Heinrich MR; Strasser A
    Bioorg Med Chem Lett; 2016 Jan; 26(2):292-300. PubMed ID: 26718844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of novel histamine H4 receptor antagonists.
    Lane CA; Hay D; Mowbray CE; Paradowski M; Selby MD; Swain NA; Williams DH
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1156-9. PubMed ID: 22189138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations.
    Krueger KM; Witte DG; Ireland-Denny L; Miller TR; Baranowski JL; Buckner S; Milicic I; Esbenshade TA; Hancock AA
    J Pharmacol Exp Ther; 2005 Jul; 314(1):271-81. PubMed ID: 15821027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the histamine H4 receptor binding site. Part 1. Synthesis and pharmacological evaluation of dibenzodiazepine derivatives.
    Smits RA; Lim HD; Stegink B; Bakker RA; de Esch IJ; Leurs R
    J Med Chem; 2006 Jul; 49(15):4512-6. PubMed ID: 16854056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological profile of astemizole-derived compounds at the histamine H1 and H4 receptor--H1/H4 receptor selectivity.
    Wagner E; Wittmann HJ; Elz S; Strasser A
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Mar; 387(3):235-50. PubMed ID: 24241585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and evaluation of a 2-benzothiazolylphenylmethyl ether class of histamine H4 receptor antagonists.
    Labeeuw O; Levoin N; Billot X; Danvy D; Calmels T; Krief S; Ligneau X; Berrebi-Bertrand I; Robert P; Lecomte JM; Schwartz JC; Capet M
    Bioorg Med Chem Lett; 2016 Nov; 26(21):5263-5266. PubMed ID: 27692832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detailed analysis of biased histamine H₄ receptor signalling by JNJ 7777120 analogues.
    Nijmeijer S; Vischer HF; Sirci F; Schultes S; Engelhardt H; de Graaf C; Rosethorne EM; Charlton SJ; Leurs R
    Br J Pharmacol; 2013 Sep; 170(1):78-88. PubMed ID: 23351115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The alkaloid conessine and analogues as potent histamine H3 receptor antagonists.
    Zhao C; Sun M; Bennani YL; Gopalakrishnan SM; Witte DG; Miller TR; Krueger KM; Browman KE; Thiffault C; Wetter J; Marsh KC; Hancock AA; Esbenshade TA; Cowart MD
    J Med Chem; 2008 Sep; 51(17):5423-30. PubMed ID: 18683917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and structure-activity relationships of novel arylpiperazines as potent and selective agonists of the melanocortin subtype-4 receptor.
    Richardson TI; Ornstein PL; Briner K; Fisher MJ; Backer RT; Biggers CK; Clay MP; Emmerson PJ; Hertel LW; Hsiung HM; Husain S; Kahl SD; Lee JA; Lindstrom TD; Martinelli MJ; Mayer JP; Mullaney JT; O'Brien TP; Pawlak JM; Revell KD; Shah J; Zgombick JM; Herr RJ; Melekhov A; Sampson PB; King CH
    J Med Chem; 2004 Jan; 47(3):744-55. PubMed ID: 14736255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tricyclic aminopyrimidine histamine H4 receptor antagonists.
    Savall BM; Gomez L; Chavez F; Curtis M; Meduna SP; Kearney A; Dunford P; Cowden J; Thurmond RL; Grice C; Edwards JP
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6577-81. PubMed ID: 21920744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of 2-arylbenzimidazoles as potent human histamine H4 receptor ligands.
    Lee-Dutra A; Arienti KL; Buzard DJ; Hack MD; Khatuya H; Desai PJ; Nguyen S; Thurmond RL; Karlsson L; Edwards JP; Breitenbucher JG
    Bioorg Med Chem Lett; 2006 Dec; 16(23):6043-8. PubMed ID: 16990005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ether derivatives of 3-piperidinopropan-1-ol as non-imidazole histamine H3 receptor antagonists.
    Łazewska D; Ligneau X; Schwartz JC; Schunack W; Stark H; Kieć-Kononowicz K
    Bioorg Med Chem; 2006 May; 14(10):3522-9. PubMed ID: 16466921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.